We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




First Of Its Kind Blood Test Accurately Predicts Preterm Birth Risk

By LabMedica International staff writers
Posted on 17 Jan 2025
Print article
Image: The test examines how immune cells react to common challenges during pregnancy (Photo courtesy of OSU)
Image: The test examines how immune cells react to common challenges during pregnancy (Photo courtesy of OSU)

Preterm birth is one of the leading causes of childhood mortality worldwide. The World Health Organization reports that over 15 million babies are born prematurely each year, with more than a million of them not surviving. Approximately 70% of preterm births occur spontaneously, without a medical indication. Black mothers are also twice as likely to experience preterm birth compared to White mothers, although the reasons for this disparity remain unclear. Now, a groundbreaking blood test has been developed that may predict the risk of preterm birth early in pregnancy.

Researchers at The Ohio State University (Columbus, OH, USA) developed this new blood test after studying various risk factors for preterm birth, including stressors such as early life adversity and experiences of racial discrimination. They discovered that persistent stress, poor sleep, depression, and anxiety can subtly alter the functioning of the immune system over time. These changes in immune function can be detected with a simple blood test, requiring less than a teaspoon of blood. Initial tests of the blood test show promising potential, with the ability to predict the risk of preterm birth with accuracy as high as 97.5%.

The researchers suggest that the test could be incorporated into the "prenatal battery," a set of screenings designed to help clinicians identify factors that may increase a patient's risk of preterm birth, allowing for early interventions before any symptoms appear. The team is now working to conduct a larger and more comprehensive study to ensure the test's accuracy in diverse patient populations. They are also exploring treatments that could "reset" the immune system’s responses to normal levels to further reduce the risk of preterm birth.

“We’re essentially trying to create this ‘crystal ball’ of future events. We are truly producing a future likely scenario early in pregnancy. And so, if the body’s not responding in the right way, we can see that,” said Shannon Gillespie, PhD, RN, FAAN, assistant professor at Ohio State’s College of Nursing. “It should feel as simple as a test for anemia. So things that can be available for everyone that’s interested.”

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.